Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, Aim Immunotech, Akan, Astrazeneca, Biontech, BMS, Celltrion, Cortexyme, Cytocom, Daiichi Sankyo, Forge Biologics, G1, Jazz, JCR, Pfizer, Pharmsynthez PJSC, Sesen, Signature, Sobi, Targovax, Xenetic.